Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Development of novel anti-cancer immunotherapy against mesothelioma comprising of oncolytic adenovirus vectors armed with ICOS and CD40 ligands in combination with checkpoint inhibitors anti-PD-1 and anti-CTLA-4

2022/47/D/NZ7/03212

Keywords:

immuno-oncology oncolytic adenoviruses CD40 ligand ICOS ligand checkpoint inhibitors anti-PD-1 anti-CTLA-4 preclinical studies

Descriptors:

  • NZ6_5: Virology
  • NZ7_14: Pharmacy, pharmacotherapy, pharmacology

Panel:

NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution :

Narodowy Instytut Zdrowia Publicznego PZH - Państwowy Instytut Badawczy

woj. mazowieckie

Other projects carried out by the institution 

Principal investigator (from the host institution):

dr Łukasz Kuryk 

Number of co-investigators in the project: 5

Call: SONATA 18 - announced on 2022-07-15

Amount awarded: 1 930 370 PLN

Project start date (Y-m-d): 2023-07-06

Project end date (Y-m-d): 2026-07-05

Project duration:: 36 months (the same as in the proposal)

Project status: Pending project

Project description

Download the project description in a pdf file

Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.